Noridian covers Botox for bladder: Use unlisted code

Why This Topic Matters

The update affects how a covered bladder procedure is reported and documented under a Medicare local policy, including how supplies and wastage are handled. It may influence claims preparation, recordkeeping, and payer-specific workflow for practices in the affected states.

Article Sections

1. Coverage update and affected diagnoses

   Introduces the Medicare contractor policy change and identifies the broad clinical situations addressed by the coverage update. Also notes the effective date and the general nature of the service involved.

2. Billing guidance and geographic scope

   Summarizes the reported billing approach for the procedure and the supply reporting discussed in the article. Also identifies the Medicare jurisdictions affected by the policy.

3. Clinical background and temporary effect of treatment

   Provides general background on the treatment approach and its temporary nature. Mentions organizational and clinical context without giving detailed coding rules.

4. Coverage expectations and prior-conservative-treatment concepts

   Describes the article’s overview of coverage expectations for invasive incontinence treatment under the local policy. Discusses the need for prior conservative management in broad terms.

5. Billing tip: Botox wastage

   Addresses documentation and billing considerations when there is unused product after treatment. The section focuses on general recordkeeping and claim submission issues.